About: Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 1983

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1983 (uk) article scientifique publié en 1983 (fr) im August 1983 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 1983 (ast) scientific article published on 01 August 1983 (en)
publication date	wds:Q71768020-99135A71-823E-4611-AF62-BA3265169FA0
publication date	1983-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71768020-164F9654-DB72-442A-95F3-1574145AAFF0
language of work or name	English
cites work	wds:Q71768020-26DE98F4-5D25-48FC-99B5-04F9E02A496A wds:Q71768020-604B0695-DBF2-41AD-80A2-BB453CA61A9E wds:Q71768020-6E5830D9-A570-467F-B0C4-92FA0677BD10 wds:Q71768020-74F0B448-DEA2-4B1E-810B-3EE58E97F5D0 wds:Q71768020-A347C47B-2A61-4389-91CD-4C645E678700 wds:Q71768020-C7410978-375B-4E3E-BEF0-48D7C28F4063 wds:Q71768020-F3FA3C95-246A-42D0-9D85-274474EDDCC5 wds:Q71768020-F8BD67EE-4A25-465A-8593-64FC0F7AE223
cites work	Treadmill exercise in assessment of the functional capacity of patients with cardiac disease Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Heart failure in outpatients: a randomized trial of digoxin versus placebo Rebound Hemodynamic Events after the Abrupt Withdrawal of Nitroprusside in Patients with Severe Chronic Heart Failure Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of disease Long-term digitalis therapy improves left ventricular function in heart failure Adequacy of the Haldane transformation in the computation of exercise V O2 in man A new inotropic drug: its promise and a caution
author name string	wds:Q71768020-2615DAD5-B804-4812-B5D7-AA9FB52680A2 wds:Q71768020-7408CB62-3961-47D6-A4B4-ECA1B0BEE71A wds:Q71768020-7A355E8D-6438-4854-9E06-27A051D17ABD wds:Q71768020-8223F4F7-52DA-4E2F-8A72-CD16FCB393E3 wds:Q71768020-94BE3279-C9D1-4EBC-A415-B1767FD6C84A wds:Q71768020-E96EC466-BCAE-408B-80D6-929E6A093C69
author name string	E H Sonnenblick B Chadwick T H Le Jemtel C S Maskin R Forman L S Sinoway
rdfs:label	Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease (en) Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease (nl)
skos:prefLabel	Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease (en) Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease (nl)
name	Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease (en) Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease (nl)
title	wds:Q71768020-F24C48CC-2907-4BBE-9798-E4D3CF1DDEA7
title	Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease (en)
page(s)	wds:Q71768020-9F06D798-4B62-455E-AB6A-6C628C7F5F51
page(s)	327-331
instance of	wds:Q71768020-6D037DAB-8E88-4617-B069-DD081C4C7D36
instance of	scholarly article
PubMed ID	wds:Q71768020-438A3B24-BC86-46C1-B87A-EA7F714384C8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6863765
PubMed ID	6863765
published in	wds:Q71768020-700EA6D3-3F3A-4546-8D33-106198595107
published in	Journal of the American College of Cardiology
issue	wds:Q71768020-232DDC3A-C878-490B-A948-A686B501732E
volume	wds:Q71768020-F39656F9-3888-4FB9-AC1C-40009E369753
issue	2
volume	2
DOI	wds:Q71768020-BD0B4C66-0F7E-445D-86D9-783A0024D3A4
DOI	http://dx.doi.org/10.1016/S0735-1097(83)80170-3
DOI	10.1016/S0735-1097(83)80170-3
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71768020
is cites work of	Acute hemodynamic effects of a new inotropic agent (OPC-8212) in patients with congestive heart failure PDE3 inhibition in dilated cardiomyopathy Newer positive inotropic agents in the treatment of chronic cardiac failure. Current status and future directions Evaluating the efficacy of new inotropic agents Phosphodiesterase inhibition in heart failure Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family Milrinone. A preliminary review of its pharmacological properties and therapeutic use. Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphate PDE3 inhibition in dilated cardiomyopathy: reasons to reconsider Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study. Prognostic factors affecting diagnosis and treatment of congestive heart failure Survival of patients with severe congestive heart failure treated with oral milrinone Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation. Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations Milrinone in heart failure. Acute effects on left ventricular systolic function and myocardial metabolism Current Status of Phosphodiesterase Inhibitors in the Treatment of Congestive Heart Failure Inotropic therapy of the failing myocardium The new inotropic phosphodiesterase inhibitors Milrinone in heart failure. Effects on exercise haemodynamics during short term treatment Drugs and the heart four years on. Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering? Functions of PDE3 Isoforms in Cardiac Muscle. Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment Additive positive inotropic effects of milrinone, ouabain and calcium in diseased human ventricular myocardium Therapeutic strategies in congestive heart failure and the new inotrope-vasodilator agents Congestive heart failure The effect of milrinone on hemodynamic and gas exchange parameters in children
is cites work of	wds:Q35668903-278606B0-EBDC-4E43-B855-58F504035B48 wds:Q38730614-E181742E-0498-4FC1-9659-59C5C72F9017 wds:Q54409186-38B5BBDE-F1C5-48FA-BA1F-1B614FEF2CB9 wds:Q37941174-47AE9172-1362-4985-8413-931E7BBDC2CC wds:Q38215916-8942961B-0DD2-44CA-BE17-0696931B6DB5 wds:Q33706835-984EB4F8-5852-482C-A02B-6774EA948DBD wds:Q34687109-83AC617F-B320-44CE-B549-161F71C637B6 wds:Q37355108-3DF8099A-34E5-49AF-AA39-C2B115614695

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software